CA1059788A - Multichamber cuvette - Google Patents

Multichamber cuvette

Info

Publication number
CA1059788A
CA1059788A CA266,162A CA266162A CA1059788A CA 1059788 A CA1059788 A CA 1059788A CA 266162 A CA266162 A CA 266162A CA 1059788 A CA1059788 A CA 1059788A
Authority
CA
Canada
Prior art keywords
chambers
passageway
article
chamber
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA266,162A
Other languages
French (fr)
Inventor
Abraham Gordon
Gregory A. Farrell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Technicon Instruments Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technicon Instruments Corp filed Critical Technicon Instruments Corp
Application granted granted Critical
Publication of CA1059788A publication Critical patent/CA1059788A/en
Expired legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03Cuvette constructions
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03Cuvette constructions
    • G01N2021/0346Capillary cells; Microcells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/11Automated chemical analysis
    • Y10T436/113332Automated chemical analysis with conveyance of sample along a test line in a container or rack

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Clinical Laboratory Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Optical Measuring Cells (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Devices For Use In Laboratory Experiments (AREA)

Abstract

ABSTRACT OF THE DISCLOSURE
A multichamber cuvette for maintaining in independent and separate condition at least two reactants one of which may be a sample, until such time that it is desired to mix them for reaction with each other for photometric analysis in the cuvette.
At least one of the chambers has a pair of optical quality windows which windows are aligned with one another for analysis of the then liquid contents extending between the windows. The uvette body is of upright construction, defining at least two such chambers laterally of one another, open at the top for filling separately or simultaneously, and interconnected adjacent their lower extremities by a passageway of inverted U shape. The passageway is of an effective height exceeding the highest filling level of each chamber by a distance at least as great as any capillary rise in the passageway beyond such level of the particular liquid in that chamber. Accidental mixing of the-chamber contents is prevented by entrapment of air in the passage-way by the respective liquids in the chambers and partially filling the legs of the passageway. The resistance of the entrapped air to such mixing through the passageway mar be over-come at the time mixing is desired by the forced flow of fluids therethrough from one chamber to the other while one of the chambers is vented to the atmosphere at the top. The passageway is so configured and also dimensioned in cross section as to allow for the free flow of liquid between the chambers once the entrapped air within the passageway has been removed.

Description

~C~S~7~
BACKGROUND OF THE IN~NTION
.
1. Field of the Invention This invention relates to a multichamber cuvette and relates more particularly to such cuvette which, while not limited thereto, is especially useful in quantitative analysis by optical density in an automated manner of a constituent of body fluids such as blood or urine for example.
2. Prior Art Brown et al U.S. Patent 3,691,017 and Mailen U.S. Patent
3,795,451 are typical of the prior art. Brown et al disclosed a multichamber cuvette for analysis of a constituent of interest in body fluids by an optical density determination in an automated manner. It was disclosed by Brown et al that a reaction may be measured in the c~vette at one point in its duration or at its end point or a reaction in the cuvette may be temperature-and-time dependent and of the type measured over a period of time to indicate the quantity of the constituent of interest by the rate of the reaction. In accordance with Brown et al, in such kinetic or rate reaction analysis of an enzyme, a trigger or key reactant component, initially located in a first chamber in restricted communication with a second chamber through a passageway, was of .
a substrate of an enzymatically catalyzed reaction with a reactant component in the second chamber. After a solvent medium had been introduced in ~he chambers to reconstitute the reagents previously in lyophilized form therein! a liquid sample comprising the cataly~ing enz~me was introducPd into the second chamber prior to forceful in~ection thereinto through the aforementioned passage-way of the key substance for the reaction to proceed under ywl/c~ 3 378~3 temperature-controlled conditions.
The cuvette was found to have many drawba¢ks in practice adversely affecting analysis among which, of a more serious type, were that the cuvette had a lower passageway interconnecting the chamhers through wh ch a diluent such as water flowed on recon-stitution of the lyophilized reagents. In accordance with Brown et al, only a single diluent injection was utilized to reconstitute the different reagents in both chambers. This injection was made into the second chamber for partial retention therein and partial 10w therethrough and through the passageway into the first chamber for retention in the latter, resulting in a high degree of risk of comingling the reagents prior to intentional mixing thereof. This construction and use of the cuvette enabled a small quantity of one of the liquid reagents in one chamber to ; migrate into and commence reaction with the other liquid reagent in the other chamber during the period of time when it was desired ; to maintain the last-mentioned liquids in complete isolation from one another, as during incubation, to prevent their premature reaction with one another. It was found that migration by diffusion of only 3% of the reconstituted aforementioned trigger or key component into the aforementioned second chamber was sufficient to invalidate an analysis. Such reagent migration might be occasioned by jarring the cuvette, for example. In view of the foregoing, it will be appreciated that the aforementioned reconstituted reagents in the ~wo chambers of the cuvette were in liquid interfacing relationship in the area of the aforementioned passageway prior to intentional mixing of the reagents, and that such reagent migration discussed above was in fact was likely ywl/c(~ ~ 4 ~5~

unless the cuvette was handled with extreme care.
The Mailen U.S. Patent 3,795,451 disclosed a rotor for mixing sample and reagent liquids loaded thereinto for use in a photometric analyzer of the rotary sample-analysis cuvette type.
Inner and outer concentric arrays of loading cavities were dis-posed within the rotor on a one to one basis centripetal to an array of sample analysis cuvettes. Liquid communication was provided by capillary-sized passageways between the respective sample, reagent and analysis cavities and cuvettes upon rota~ion of the rotor, while intercontact of the liquids in the respective cavities was prevented under static loading conditions. The aforementioned respective passageways between the inner and outer cavities were each provided with an air lock in the form of a bubble trap under static conditions.
The present invention overcomes difficulties in the prior art.
SUMMARY OF TEIE INVENTION
One object of the invention is to provide a multichamber cuvette having an improved structure for maintaining in independent ~0 and separate condition at least two reactants one of which may be a sample, until such time that it is desired to mix them for reaction with each other while in a cuvette for analysis in the cuvette, and which enables a large measure of free flow of the reactants during the mixing thereof. Further, there is provided a cuvette body of upright construction, defining at least two such chambers laterally of one another, open at the top for filling separately or simultaneously, and interconnected adjacent their lower extremities by a passageway of inverted U-shape. The ywl/ 5 7~8 passageway is of an effective height exceeding the highest filling level of each chamber by a distance at least as great as any capillary rise in the passageway beyond such level of the particular liquid in that chamber. Accidental mixing of the chambers ~ontents is prevented by entrapped of air in the passageway by the respective liquids in the chambers and partially filling the legs of the passageway. The resistance of the entrapped air to such mixing through the passageway may be over-come at the time mixing is desired by the forced flow of fluid therethrough from one chamber to the other while one of the chambers is vented to the atmosphere. The passageway is so configured and also dimensioned in cross-sectioned as to allow for the free flow of liquid between the chambers once the entrapped air in the passageway has been removed.
` Other objects of the invention will be apparent from the detailed description of the preferred embodiment of the invention set forth hereinafter.
BRIEF DESCRIPTION OF THE DRAWINGS
In the drawings:
Fig~ 1 is an exploded view of a cuvette body embodying the invention;
Fig. 2 is a rear elevational view of the cuvette body showing the same with a top cover and illustrating typical liqui`d levels in two chambers of the body after mixing of such chamber contents;
Fig. 3 is a view similar to Fig. 2 but illustrating a front, elevational section o~ the cuvette and showing typical liquid levels in the two chambers just prior to mixing of the chamber ywl/~ 6 -5~3~78~3 contents;
Fig. 4 is a schematic view, similar to Fig. 3, with the top cover removed and illustrating different liqui~ reagents deposited in the respecti~e chambers prior to lyophilization of such reagents at typical filling heights;
Fig. 5 is a view similar to Fig. 4 showing the reagents in the last mentioned chambers in lyophilized form at typical heights just prior to the application of the top cover to the body;
Figs. 6, 7 and 8 are enlarged sectional views taken on lines 6-6, 7-7, and 8-8, respectively; and Figs. 9 and 10 are schematic views illustrating the effectiveness of the barrier isolating li~uids in chambers of the cuvette under different conditions, and appear on the same sheet as Fig. 4.
`` DETAILED DESCRIPTION OF THE PREFERRED EM~ODIMENTS
There is best shown in Figs~ 1 and 2 the general organiza-tion of the parts of the cuvette in which the main cuvette body is indicated at 10, a planar rear cover portion of the body at 12 and the top co~er of the cuvette at: 14. The main body 10 may be molded in one piece of optical gracle transparent plastic material.
; The rear cover portion 12 may also be molded as a single part of suitable plastic material without regard to transparency. The main body 10 has a generally flat, front face 16 (Fig. 7) except in the region of an optical window 18 therein which may be recessed~
two sides 20, 21 (Fig~ 1), and a rear face 22 (Figs. 1 and 2) which in its lateral and upper marginal portions is generally flat except in the region of the optical window 24 which may be recessed and is in alignment with the aforementioned window 18.

".
ywl/C'~ - 7 - `

~L~S9~88 In the generally central region of the rear face there is an upwardly extending recess through the lowex ex~remity thereof to a location approaching the top thereof, which recess is best shown in Fig. 1 and indicated at 26. The recess 26 has the outline indicated in the last mentioned view and receives the complemental rear cover portion 12 of the cuvette body so that the latter is substantially flush with the lateral margins of the rear face of the body in the rear cover portion's assembled condition as shown in Fig. 7. The recess 26 has a pair of wing-like like lateral ~10 extensions 28 through each oX which extensions 28 there is provided one of a pair of fluid-passing orifices 30 extending through the rear face of the cuvette body. In the assembled cuvette body, the orifices 30 register with the respective legs of an inverted generally U-shaped groove 32 in the near face of the cover portion 12 which groove is preferably semi~ircular in cross section. In assembled condi~ion, the rear cover portion 12 is suitably welded in place in fluid-and~water-tight relation to the main body to prevent leakage between the lattex and rear cover portion 12 and prevent any leakage out of the generally U-shaped passageway 32a : 20 (Fig. 4 for example) formed by the orifices 30, the groove 32 in the,rea.r cover portion 12 and the bottom of the recessed portion 26 of the main body~
As shown in Figs. 1 and 3, the interior of the main body 10 is vertically compartmented by laterally spaced walls 36, 38 extending between the front and rear faces of the cuvette body and which form, together with the near sides of the main body and respective bottom portions 38 extending therebetween, a first upwardly opening first chamber 40 and an upwardly opening second ywl/~ 8 --~la)5~788 chambex 42. The orifioes 30 communicate with the chambers 40, 42, respectively. Intermediate the upper and lower extremities of the walls 36, 38 and extending between these walls is a portion 44 of the main body 10 which forms, together with the front and rear faces of the main body, an upwardly opening chamber 46 between the chamber~ 40, 42 and which ma~ be relatively shallow as indicated in Fig. 3.
The bottom portions 38 of the chambers 40, 42 have in the central regions thereof, respectively, upwardly pro~ecting cones 48. The main body 10 has a laterally extending lip 50 around the upper extremity thereof to which the cuvette cover 14 is secured.
The cover 14 (Fig. 2) is preferahly a probe-puncturable laminate which provides a moisture and gas barrier the construction and use of which is not part of the present invention. There is an ~rdly extending recess 52 (Fig. 3~ centrally of the main body 10, the bottom of which recess is formed by the portion 44. The chamber 46 may be utilized to hold a liquicl sample, for example, prior to deposit of a portion thereof in one of the chambers 40, 42~
As shown in Fig. 2, for example, the lower end portions of the legs of the groove 32 of generally inverted U-shape are gently-flared outwardly or inc~ined as at 33. This permits registration - of the leg portions with the respective orifices 30, while enabling narrowing of the upper portion of the inverted U-shaped groove 32 so that it may be laterally separated from the optical window 24, as shown in Fig. 2. The aforementioned gently flared portions 33 of the groove 32 minimizes restriction of flow in the passageway 32a. Further as shown in the last-mentioned view, the top portion of the groove 32 is shaped on a substantial radius so as to min~ze ywl/~p _ g_ la3S!~7~
restriction of flow in the passageway. The main body 10 and the rear cover portion 12 are so shaped (Figs. 1 and 2) that the two may be easily assembled. For this purpose, the rear cover portion 12 is placed in parellel, face-to-face relation with the recess 26 and the two parts are brought together. It is to be noted that the configuration of the recess 26 is such as to support the rear cover portion 12 when assembled, that is, the top and lower portions of the recess 26 prevent any relative sliding movement between the main body 10 and the rear cover portion 12 once they are assembled. When the parts are so assembled the orifices 30 register in the aforementioned manner with the groove 32 in the rear cover portion 12.
One type of use to which the cuvette may be put, while~
not limiting the use thexeof, is as follows. Such use may be - for the quantitative determination of lactic dehydrogenase in a sample of blood serum. The reagents employed are lactic acid, the key component or trigger for the reaction~ and nicotinamide adenine dinucleotide (NAD) with an appropriate buffer (tris [hydroxymethyl] amino methane) in order to maintain the pH. As shown in Fig. 4, the lactic acid 54 is deposited in solution in the first chamber 40 and the NAD/buffer in solution 56 is deposited in second chamber 42 in measured amounts while the cover 14 is removedO These solutions fill these chambers over the level of the orifices 30 and extend a short distance into the passageway 32a, one having more head than the other. The solutions are deposited either separately or simultaneously and in so doing-entrap air in the passageway 32a which acts as a barrier between the liquids. The chamber contents are lyophilized or freeze yWl/c(~p - 10 -13D5978i3 dried and an atmosphere of inert gas or dry air is added after which the cover 14 is secured in position on the lip 50 of the main body 10. The reagents may be stored in this condition for considerable periods of time or the cuvette may be used immediately for analysis. The lyophilized lactic acid 58, or trigger reagent, and the lyophilized N~D reagent 60 are shown in Fig. 5, in which condition the reagents are in the form of cakes which adhere to the upward projections 48 from the bottoms of the respective chambers. Further, in this condition, the lyophilized ~0 reagents 58, 60 may extend a short distance through the respective orifices 30~ The passageway 32a isolates such lyophilized reagents.
When the analysis is to be performed, a hypodermic needle indicated by arrow 62 (Fig. 3) aspirates (not shown) a predetermined amount of blood serum from a suitable source and -subsequently punctures the cover in the area of chamber 42 to introduce such blood serum into the last mentioned chamber in a single injection, together with a quantity of a diluent, which in this instance is water to reconstitute the lyophilized reagent in the chamber, the reconstituted reagent being indicated at 64 as shown in the last-mentioned view. Substantially simultaneously ~or separately~, with the dispensing in chamber 42 the hypodermic needle indicated by an arrow 66 in the last-mentioned view, having punctured the cover 12 in the area of the chamber 40, dispenses water as diluent for this analysis in the proper volume in that chamber to reconstitute the lyophilize reagent therein.
The last-mentioned reconstituted reagent is indicated at 68.
The reagents remain isoloated from each other by air trapped in the passageway 32a. In the serum deterination under discussion, the ywl/~c~Q

~S9788 relative amounts of the serum, lactic acid reagent, and the NAD
reagent which enter into the aforementioned reaction have been disregarded in illustrating the heights to which the chambers 40 and 42 are filled, which heights are purely by way of illustration and not necessarily those used in practice in the par~icular analysis under discussion.
The fluid contents of the chambers 40, 42 are then incubated under temperature-controlled conditions to be brought to the desired reaction temperature which is usually 30 or 37C.
Subsequent to such incubation, a hollow probe, indicated by an arrow 70 in Fig. 2, may puncture the cuvette cover 14 in the area over the chamber 42, for example to alternately apply air under pressure and create a vacuum suficient to dislodge from the passageway 32a any solids (such as reagents not completely dissolved) and the air trapped in the upper portion thereof so as ~o permit the free flow of liquid from one chamber to the other through the passageway during mixing, the cover 14 over the chamber 40 being suitably vented to atmosphere. As may cycles of applied pressure and vacuum may be employed as re~uired for such mixing of the chamber contents. The orifices 30 may be approxi mately 0.065" in diameter, for example, and the groove 32 forming part of the inverted U-shaped passageway 32a may have approximately the same cross-sectional dimension of each orifice 30.
The passageway 32a is of an effective height exceeding the highest filling level of each chamber by a distance at least as great as any capillary rise in the passageway 32a beyond such level of the particular liquid in that chamber. Three considerations should be made in the determination of the proper longitudinal ywl/,~ - 12 -~5~978~3 and cross-sectional dimensions of the passageway 32a. The first of these is that the passageway 32a should be as short as possible between the chambers 40, 42 for mixing in the shortest possible time. The volume transferred from one chamber to the other chamber in one half of the aforementioned cycle should be as large as possible. The second consideration is that the passageway 32a of inverted U-shape should be of an effective height to isolate the contents of the chambers under all conditions until intentional mixing of the chamber contents takes place. The third consideration is that the passageway 32a should have the least possible resistanoe to the free flow of liquid between the chambers durlng mixing.
Obviously, these considerations do not lend themselves one to another hut these considerations lead to an optimal passageway 32a cross section and length for given conditions such as, for example, desired barrier effect, duration oE mixing cycle and liquid-fill volumes. Subsequent to such mixing, the liquid levels in the chambers are substantially the same as shown in Fig. 2.
It is to be noted that during back-and-forth mixing of the chamber contents, the entry of liquid flowing into each chamber 2~ through the corresponding orifice 30 is tangential to an imaginary circle, of substantial radius, the centex of which is located in the center of the bottom of the chamber. This produces a rotary and spiral flow of liquid into the chamber, and the provision of the upwardly projecting cone 48 in the center of the chamber bottom aids mixing by eliminating a stagnant portion in the flow in the central region of such rotary flow, thereby enhancing the rate of mixing.
When the mixing of the chamber contents has been completed, ~ .
ywl/C~ 13 -any lactic dehydrogenase in the blood serum sample acts as a catalyst which catalyzes the reaction to form as reaction products pyruvic acid and NADH. Since NADH which is produced as a reaction product, has a substantially higher optical density th~n does NAD, the rate of any increase in optical density is a function of the amount of lactic dehydrogenase in the sample. After the initiation of the reaction as the result of comingling the substrate with the other reaction components, the reaction rate may be determined by placing the cuvette in a position with reference to a nonillustrated photometric analyzer wherein light from a source at a wavelength of 340 nm passes through the transparent windows, 18, 24 of the cuvette and through the ~hickness of the reaction mass between the two windows. Any change in optical density per unit of time may be measured and the data thus obtained may be translated into values indicative of the quantity of lactic dehydrogenase contained in the serum sample.
Figs. 9 and 10, as previously indicated, illustrate the efectiveness of the passageway 32a as a barrier isolating liquids in the chambers 40, 42, under different conditions, prior to any intentional mixing of liquids of said chambers. Fig. 9 illustrates a technique of reconstituting the lyophilized reagent in the chamber 40 to its completion prior to reconstituting the lyophilized reagent 60. Fig. 10 illustrates the barrier condition subsequent to separate reconstituting of the lyophilized reagent 60 in chamber 42, including the addition of the serum sample in the chamber 42 with the reconstituting medium. For simplicity of illustration and description, the final fill levels in chambers 40, 42 are the same.

ywl/~c~ 14 -~S~7l~8 As previously indicated, the passageway 32a of the cuvette is of an effective height exceeding the highest filling level of each chamber by a distance at least as great as any capillary rise in the passageway beyond such level of the particular liquid in that chamber. Such capillary rise in the passageway 32a will depend upon the cross-sectional dimension of the passageway 32a and the degree to which the particular liquid wets the internal surface of the passageway 32a. In both Figs. 9 and 10, it is assumed that both chambers 40, 42 are vented to the atmosphere during the filling. As known in the art, these chambers may be vented in a variety of ways. By way of example only, in Figs. 9 and 10, respectiveIy, dispensing probes which puncture the cover 14 to enter the chambers 40, 42, respectively, may be of the self-venting type indicated by arrows 74, 78 respectively. For example, in Flg. 9, chamber ~2 is vented by tube 76 open to the atmosphere and penetrating the cover, while in Fig. lQ the tube 76 is shown penetrating the cover over the chamber 40 ~o vent the latter. In Fig. 9, Hpi indicates the initial liquid height in the leg of the passageway 32a near the chamber 40, the reconstituted reagent being indicated at 71. As shown in Fig. 9, Ht indicates the effective height of the inverted U-shaped passageway 32a and ~c indicates capillary rise in the near leg of the passageway 32a with respect to a filling level Hl in the chamker 40. The foregoing assumes that during the filling of chamber 40 to the last-mentioned level therein, which level is by way of example only, air is free to pass through the passageway 32a including any lyophilized reagent 60 extending into the passageway 32a. If, in fact, lyophilized reagent 60 does not allow free air passage through the passageway ywl/~ 15 r--~
~5~7~

32a on reconstituting of the reagent in chamber 40t Hc is reduced or eliminated. For this reason, among others, Hc may not be a factor.
Subsequent to the filling of chamber 42, to the level indicated, to effect the reagent-sample mixture 72 in Fig. 10, the heisht of the reconstituted reagent 71 in the near leg of the passageway 32a is reduced as indicated by a comparison of Figs. 9 and 10, and the levels in both legs of the passageway in this example are the same and less than the filling heights in the chambers 40, 42. As shown in Fig. 10, Hp~ is equal to Hl + HCj2:
The effective barrier to mixing provided in the passageway 32a is that shown in the last-mentioned view or Ht-Hpf. ~When the chambers 40, 42 are filled as aforesaid to the same filling levels of Fig.
10 but in a nonillugtrated simultaneous manner through non-illustxated twin vented probes extending through the cover 14, Hpf is substantially reduced and there is no rise at any time in such filling in the legs of the passageway 32a beyond the last-mentioned filling levels. The same result is achieved when the last-mentloned twin dispensing probes commence filling the chambers 40, 42 substantially at the same time, that is, so that the orifices 30 are covered by the dispensed liquid at approximately the same - ~ time. Figs. 3-5 illustrate liquid and solid heights in the chambers 40, 42 and in the legs of the inverted U-shaped passage-way 32a when the chambers 40, 42 are loaded substantially simultaneously and to different levels. Obviously, the cuvette may be utilized without the above-described reagent lyophilization and reconstitution steps, as by initially filling chambers 40, 42 to the liquid levels of Fig. 3 for example. With the liquid ywl/,lc.~ - 16 -1~5978B
filling levels shown in the last-mentioned view, the cuvette may be tilted accidentally, right or left, within a substantial range of angles without loss of the barrier effect of passageway 32a.
As shown in Fig. 7, the inverted U-shaped passageway 32a has a compound cross section where each orifice 30 communicates with the respective leg portion of such passageway. As indicated by the last~mentioned view, when compared to Fig. 3 for example, the passageway 32a has a horizontal cross section of greatest dimension substantially less than the horizontal cross section of smallest dimension of either of the chambers 40, 42.
While the preferred embodiments of the cuvette have been illustrated and described, it will be apparent, especially to those versed in the art, that the cuvette may take other forms and is susceptible to various changes in details without departing from the principlesiof the invention.

, .

..~
ywl/~ 17 -

Claims (18)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A cuvette body, comprising: means defining first and second upright laterally-spaced liquid-receiving chambers at least one of which has a liquid-receiving inlet, passageway means inter-connecting lower portions of said chambers, said passageway means having a horizontal cross section of greatest dimension substan-tially less than the horizontal cross section of smallest dimen-sion of either of said chambers, said chambers having fill levels above said lower portions, said passageway means being of inverted U-shape and of a height in excess of any capillary rise when liquid of controlled volume is introduced into said one chamber.
2. An article as defined in claim 1, wherein: said chamber-defining means further defines respective upward inlet openings in said chambers.
3. An article as defined in claim 1, wherein: said chamber-defining means further defines a pair of at least wall portions of one of said chambers which wall portions are trans-parent and oppositely disposed for optical analysis of the contents of said one of the chambers.
4. An article as defined in claim 1, wherein: said passageway means is of substantially uniform cross section through-out its length.
5. An article as defined in claim 1, wherein: the upper portion of said inverted U-shaped passageway means is formed on a radius.
6. An article as defined in claim 1, further including means defining a generally conical upward projection from the central bottom region of at least one of said chambers, one end of said passageway means being generally tangential to an imaginary circle of substantial radius in said one of said chambers, the center of said circle being substantially on the vertical axis of said one of said chambers.
7. An article as defined in claim 1, wherein: said passageway means is formed in part in a planar member.
8. An article as defined in claim 7, wherein: said chamber-defining means comprises a main body, said planar member being an external cover member in fixed relation to said main body.
9. An article as defined in claim 8, wherein: said part of said passageway means defined in said cover member is formed as a groove of inverted U-shape in one face of said member.
10. An article as defined in claim 9, wherein: said groove has a cross-sectional shape formed on a radius.
11. An article as defined in claim 10, wherein: a portion of the length of said inverted U-shaped passageway means is formed between an external wall surface of said main body and said cover member.
12. An article as defined in claim 11, wherein: said passageway means comprises a pair of orifice extending through said external wall of said main body and in communication with the respective ones of said chambers and legs of said U-shaped passageway means.
13. An article as defined in claim 1, wherein, said chambers have fill levels above said lower portions and said passageway means has a height exceeding such fill levels which is, at least, in excess of any capillary rise when liquid of controlled volume is introduced into at least one of said chambers,
14. An article as defined in claim 1, further including lyophilized reagent contained in, at least, one of said chambers.
15. An article as defined in claim 14, wherein: said chambers contain an inert atmosphere and further including means for sealing said chambers.
16. An article as defined in claim 1, wherein: the central portion of said passageway has a height which approaches the level of said inlet.
17. An article as defined in claim 1, wherein: at least one of said chambers being adapted to be pressurized to support the flow of liquid from said one chamber to the other of said chambers.
18. An article as defined in claim 1, wherein: at least one of said chambers being adapted to be evacuated to support the flow of liquid from the other of said chambers to said one chamber.
CA266,162A 1976-03-01 1976-11-19 Multichamber cuvette Expired CA1059788A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/662,642 US4043678A (en) 1976-03-01 1976-03-01 Cuvette

Publications (1)

Publication Number Publication Date
CA1059788A true CA1059788A (en) 1979-08-07

Family

ID=24658542

Family Applications (1)

Application Number Title Priority Date Filing Date
CA266,162A Expired CA1059788A (en) 1976-03-01 1976-11-19 Multichamber cuvette

Country Status (15)

Country Link
US (1) US4043678A (en)
JP (1) JPS52152287A (en)
AR (1) AR210007A1 (en)
AU (1) AU497987B2 (en)
BE (1) BE849183A (en)
BR (1) BR7701227A (en)
CA (1) CA1059788A (en)
DD (1) DD129689A5 (en)
DE (1) DE2705899A1 (en)
FR (1) FR2343238A1 (en)
GB (1) GB1567480A (en)
IT (1) IT1068741B (en)
NL (1) NL7700300A (en)
SE (1) SE7702188L (en)
YU (1) YU50077A (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195060A (en) * 1978-02-08 1980-03-25 Abbott Laboratories Liquid reagent cartridge cuvette
US4605536A (en) * 1984-05-29 1986-08-12 Veb Metaplast Quedlinburg Cuvette for projection display of chemical experiments
US4578169A (en) * 1984-06-12 1986-03-25 Elvi S.P.A. Apparatus for total and fractional analyses of proteins
FI850890A0 (en) * 1985-03-06 1985-03-06 Perlos Oy KYVETTSERIE FOER BLODUNDERSOEKNING.
US5075082A (en) * 1986-07-11 1991-12-24 Beckman Instruments, Inc. Reagent cartridge
US4970053A (en) * 1986-07-11 1990-11-13 Beckman Instruments, Inc. Reagent cartridge
DE3837078A1 (en) * 1988-10-31 1990-05-03 Holger Behnk METHOD AND DEVICE FOR EXAMINING AND MEASURING THE BLOOD CLOTHING TIME
US5045208A (en) * 1989-10-27 1991-09-03 Helena Laboratories Corporation Column analyzer system
DE9016832U1 (en) * 1990-12-17 1991-03-07 Labor Laborgeraete + Analysensysteme Vertriebsgesellschaft Mbh, 2070 Ahrensburg, De
CA2067425C (en) * 1991-05-07 1996-09-24 Alfons Balmer Cuvette for optical measurements
US5478751A (en) * 1993-12-29 1995-12-26 Abbott Laboratories Self-venting immunodiagnositic devices and methods of performing assays
EP0843169B1 (en) * 1995-02-25 2003-03-19 Roche Diagnostics GmbH Device for treating samples on microscope slides
US6429007B1 (en) * 1997-05-02 2002-08-06 BIOMéRIEUX, INC. Nucleic acid amplification reaction station for disposable test devices
US6410275B1 (en) 1997-05-02 2002-06-25 Biomerieux, Inc. Disposable test devices for performing nucleic acid amplification reactions
US5989499A (en) * 1997-05-02 1999-11-23 Biomerieux, Inc. Dual chamber disposable reaction vessel for amplification reactions
US6463649B1 (en) * 1999-01-22 2002-10-15 Industrial Technology Research Institute Method of manufacturing disposable reaction module
US6284195B1 (en) * 1999-01-25 2001-09-04 Industrial Technology Research Institute Disposable reaction module
US20030017620A1 (en) * 2001-06-21 2003-01-23 Carron Keith T. Lyophilization of colloidal metals for surface enhanced Raman scattering
US6603544B1 (en) 2002-02-06 2003-08-05 Tech Ref, Inc. Sample cell
ATE388397T1 (en) * 2004-07-03 2008-03-15 Hoffmann La Roche PRECONCENTRATION CONNECTION FOR COUPLING CAPILLARY ELECTROCHROMATOGRAPHY AND CAPILLARY ZONE ELECTROPHORESIS
EP1611954A1 (en) * 2004-07-03 2006-01-04 Roche Diagnostics GmbH Liquid reservoir connector
EP1614464A1 (en) * 2004-07-03 2006-01-11 Roche Diagnostics GmbH Liquid reservoir connector
USD771383S1 (en) * 2015-06-16 2016-11-15 Vasile Vincent Crate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3691017A (en) * 1970-05-06 1972-09-12 Worthington Bio Chem Corp Means and method for chemical analysis
US3799742A (en) * 1971-12-20 1974-03-26 C Coleman Miniaturized integrated analytical test container
US3795451A (en) * 1973-04-24 1974-03-05 Atomic Energy Commission Rotor for fast analyzer of rotary cuvette type
US3829223A (en) * 1973-07-20 1974-08-13 Atomic Energy Commission Mixing rotor for fast analyzer of rotary cuvette type with means for enhancing the mixing of sample and reagent liquids
US3961899A (en) * 1974-05-28 1976-06-08 Worthington Biochemical Corporation Reaction container for chemical analysis
US3994594A (en) * 1975-08-27 1976-11-30 Technicon Instruments Corporation Cuvette and method of use

Also Published As

Publication number Publication date
NL7700300A (en) 1977-09-05
AU497987B2 (en) 1979-01-25
IT1068741B (en) 1985-03-21
DD129689A5 (en) 1978-02-01
AU2215777A (en) 1978-08-17
US4043678A (en) 1977-08-23
DE2705899A1 (en) 1977-09-08
BE849183A (en) 1977-06-08
JPS52152287A (en) 1977-12-17
GB1567480A (en) 1980-05-14
YU50077A (en) 1982-05-31
BR7701227A (en) 1977-10-18
SE7702188L (en) 1977-09-02
FR2343238A1 (en) 1977-09-30
AR210007A1 (en) 1977-06-15

Similar Documents

Publication Publication Date Title
CA1059788A (en) Multichamber cuvette
US4083638A (en) Cuvette and method of use
US4227810A (en) Cuvette and method of use
KR0179029B1 (en) Cuvette
US10101317B2 (en) Rotatable analyzing device with a separating cavity and a capillary cavity
CA1048911A (en) Reaction container for chemical analysis
WO2022116758A1 (en) Multi-functional microfluidic test chip
US5472671A (en) Cuvette
EP3521833B1 (en) Analyzing device
JPH09507572A (en) Self-ventilated immunodiagnostic device and analysis method
JPS5847241A (en) Method of executing analysis and measurement, rotor inserting element and analyzing element
US4314970A (en) Analysis system
IE52112B1 (en) An autonomous simultaneous analysis apparatus and a method of using it
CN1009492B (en) Transver flow diagnostic device
MXPA01003181A (en) Disposable test devices for performing nucleic acid amplification reactions.
CN113634296A (en) Micro-fluidic chip
US4902479A (en) Centrifugal analyzer rotor
US20100323454A1 (en) Analyzing device, and analyzing apparatus and analyzing method using the analyzing device
CA2075438C (en) Centrifugal analyzer rotors
CN211921576U (en) Micro-fluidic chip and system integrating nucleic acid extraction, amplification and detection
US20140377851A1 (en) Analysis device
CA1070139A (en) Cuvette and method of use
JPH0373812B2 (en)
JPH04348250A (en) Cuvette for centrifugal agitation
WO2014072053A1 (en) Microcuvette for biochemical assays